Cargando…
Future Projections in Thyroid Eye Disease
BACKGROUND AND AIMS: This review aims to summarize current and emerging therapies for treatment of thyroid eye disease (TED), in the light of novel understanding of pathogenetic mechanisms, leading to new treatment options and clinical trials. METHODS: We reviewed and analyzed peer-reviewed literatu...
Autores principales: | Barbesino, Giuseppe, Salvi, Mario, Freitag, Suzanne K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359449/ https://www.ncbi.nlm.nih.gov/pubmed/36346684 http://dx.doi.org/10.1210/clinem/dgac252 |
Ejemplares similares
-
Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease
por: Kossler, Andrea Lora, et al.
Publicado: (2022) -
Painful Subacute Thyroiditis is Commonly Misdiagnosed as Suspicious Thyroid Nodular Disease
por: Li, Josephine H., et al.
Publicado: (2021) -
Measuring Health-Related Quality of Life in Thyroid Eye Disease
por: Sharma, Anu, et al.
Publicado: (2022) -
Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease
por: Smith, Terry J
Publicado: (2022) -
PSAT265 Blood Glucose in Thyroid Eye Disease (TED) in Patients treated with Teprotumumab: Clinical Trials Data
por: Smith, Terry J, et al.
Publicado: (2022)